Claris Lifesciences Ltd. - Research Center
533288 CLARIS Group (B) BSE data
Results
Statement
More
| Mar ' 17 |
Mar ' 16 |
Mar ' 15 |
Dec ' 13 |
Dec ' 12 |
Equity share capital
| 54.57 |
54.57 |
54.57 |
63.82 |
63.82 |
Share application money
Preference share capital
Reserves & surplus
| 685.71 |
783.11 |
803.00 |
886.31 |
872.39 |
Secured loans
| 16.58 |
11.89 |
36.97 |
232.30 |
499.32 |
Unsecured loans
Total
| 756.86 |
849.58 |
894.55 |
1,182.43 |
1,435.53 |
Gross block
| 60.42 |
79.74 |
58.24 |
732.48 |
1,105.15 |
Less : revaluation reserve
Less : accumulated depreciation
| 10.41 |
23.57 |
19.91 |
227.35 |
300.41 |
Net block
| 50.01 |
56.17 |
38.33 |
505.13 |
804.74 |
Capital work-in-progress
| 4.17 |
6.06 |
1.77 |
173.29 |
174.27 |
Investments
| 230.30 |
691.15 |
350.88 |
627.43 |
16.66 |
Current assets, loans & advances
| 653.52 |
347.79 |
877.81 |
427.55 |
808.64 |
Less : current liabilities & provisions
| 181.14 |
251.59 |
374.25 |
550.97 |
368.77 |
Total net current assets
| 472.38 |
96.20 |
503.56 |
-123.42 |
439.87 |
Miscellaneous expenses not written
Total
| 756.86 |
849.58 |
894.55 |
1,182.43 |
1,435.53 |
Book value of unquoted investments
| 96.51 |
650.53 |
112.34 |
379.77 |
16.66 |
Market value of quoted investments
| 134.25 |
42.25 |
63.93 |
82.63 |
- |
Contingent liabilities
| 642.44 |
1,004.11 |
800.16 |
368.09 |
291.41 |
Number of equity sharesoutstanding (Lacs)
| 545.68 |
545.68 |
545.68 |
638.18 |
638.18 |